153 related articles for article (PubMed ID: 18381649)
1. Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study.
Huang X; Abbott RD; Petrovitch H; Mailman RB; Ross GW
Mov Disord; 2008 May; 23(7):1013-1018. PubMed ID: 18381649
[TBL] [Abstract][Full Text] [Related]
2. Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study.
Abbott RD; Ross GW; White LR; Sanderson WT; Burchfiel CM; Kashon M; Sharp DS; Masaki KH; Curb JD; Petrovitch H
J Neurol; 2003 Oct; 250 Suppl 3():III30-9. PubMed ID: 14579122
[TBL] [Abstract][Full Text] [Related]
3. The serum lipid profile of Parkinson's disease patients: a study from China.
Guo X; Song W; Chen K; Chen X; Zheng Z; Cao B; Huang R; Zhao B; Wu Y; Shang HF
Int J Neurosci; 2015; 125(11):838-44. PubMed ID: 25340257
[TBL] [Abstract][Full Text] [Related]
4. Long-term statin use and the risk of Parkinson's disease.
Friedman B; Lahad A; Dresner Y; Vinker S
Am J Manag Care; 2013 Aug; 19(8):626-32. PubMed ID: 24304212
[TBL] [Abstract][Full Text] [Related]
5. Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study.
Rozani V; Gurevich T; Giladi N; El-Ad B; Tsamir J; Hemo B; Peretz C
Mov Disord; 2018 Aug; 33(8):1298-1305. PubMed ID: 30145829
[TBL] [Abstract][Full Text] [Related]
6. Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease.
Huang X; Chen H; Miller WC; Mailman RB; Woodard JL; Chen PC; Xiang D; Murrow RW; Wang YZ; Poole C
Mov Disord; 2007 Feb; 22(3):377-81. PubMed ID: 17177184
[TBL] [Abstract][Full Text] [Related]
7. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
8. Coffee and tea consumption and the risk of Parkinson's disease.
Hu G; Bidel S; Jousilahti P; Antikainen R; Tuomilehto J
Mov Disord; 2007 Nov; 22(15):2242-8. PubMed ID: 17712848
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
10. Total cholesterol and the risk of Parkinson disease.
Hu G; Antikainen R; Jousilahti P; Kivipelto M; Tuomilehto J
Neurology; 2008 May; 70(21):1972-9. PubMed ID: 18401018
[TBL] [Abstract][Full Text] [Related]
11. Excessive daytime sleepiness and subsequent development of Parkinson disease.
Abbott RD; Ross GW; White LR; Tanner CM; Masaki KH; Nelson JS; Curb JD; Petrovitch H
Neurology; 2005 Nov; 65(9):1442-6. PubMed ID: 16275833
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of coffee consumption and risk of Parkinson's disease.
Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S
Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
[TBL] [Abstract][Full Text] [Related]
15. Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.
Kim SJ; Park YG; Kim JH; Han YK; Cho HK; Bang OY
Atherosclerosis; 2012 Aug; 223(2):463-7. PubMed ID: 22683121
[TBL] [Abstract][Full Text] [Related]
16. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
17. Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease.
Sääksjärvi K; Knekt P; Männistö S; Lyytinen J; Heliövaara M
Parkinsonism Relat Disord; 2015 Oct; 21(10):1148-55. PubMed ID: 26228080
[TBL] [Abstract][Full Text] [Related]
18. Cardiometabolic factors and disease duration in patients with Parkinson's disease.
Cassani E; Cereda E; Barichella M; Madio C; Cancello R; Caccialanza R; Zini M; Cilia R; Pezzoli G
Nutrition; 2013; 29(11-12):1331-5. PubMed ID: 24035054
[TBL] [Abstract][Full Text] [Related]
19. Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population.
Séguro F; Bongard V; Bérard E; Taraszkiewicz D; Ruidavets JB; Ferrières J
Arch Cardiovasc Dis; 2015 Oct; 108(10):511-8. PubMed ID: 26073227
[TBL] [Abstract][Full Text] [Related]
20. Association of olfactory dysfunction with risk for future Parkinson's disease.
Ross GW; Petrovitch H; Abbott RD; Tanner CM; Popper J; Masaki K; Launer L; White LR
Ann Neurol; 2008 Feb; 63(2):167-73. PubMed ID: 18067173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
